Pharmaceutical

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy

AstraZeneca and Ionis are intensifying their competition with Alnylam by securing an EU approval for Wainzua.

Mar 11, 2025 - 06:00
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
AstraZeneca and Ionis are intensifying their competition with Alnylam by securing an EU approval for Wainzua.
Read the original article

Tags:

Previous Article

Kenox and Lactiga partner on sIgA therapies for immunodeficiency

Next Article

Vaccinex plans Nasdaq exit as Alzheimer market pressure grows

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: ‘No data more personal’: Patients, digital health players weigh in on the FTC’s data privacy plan

STAT+: ‘No data more personal’: Patients, digital healt...

Aug 9, 2023

Parliamentarians call on G7 leaders to invest in neglected tropical diseases

Parliamentarians call on G7 leaders to invest in neglec...

May 18, 2023

STAT+: Novartis reportedly decides to pass on Cytokinetics

STAT+: Novartis reportedly decides to pass on Cytokinetics

Jan 16, 2024